Funded startups/Ascribe Bioscience Inc.
AB

Ascribe Bioscience Inc.

SEC filing
Agriculture · Ithaca, NY
Form D on EDGAR
Amount raised$15Msold at filing
Total offering$15.3M$254K still open
Investors in the raise11count reported to the SEC
FiledOct 15, 2025first sale Oct 8, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Alex BondarDirector
Fred GruisDirector
Frank SchroederDirector
Jay FarmerExecutive Officer, Director
Kyle WelbornDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DOct 15, 2025$15M$15.3MEDGAR
DOct 7, 2024$2.2M$2.2MEDGAR